Translational Stroke and Dementia Research – PI: Martin Dichgans

Martin Dichgans, PI

Read more about the PI on the next tab.

Yaw Asare / PostDoc

I joined the Dichgans lab in September 2014 after my PhD and a short postdoc stay in RWTH Aachen University (BernhagenLab). Building on my expertise in vascular signaling, the crosstalk between epigenetic regulatory mechanisms and the NFkB pathway driving vascular inflammation is a major research focus. Several in vivo mouse models of atherosclerosis and vascular injury are flanked by in vitro mechanistic studies to decifer the role of HDAC9 in vascular inflammation. We further explore the inhibition of HDAC9 as a therapeutic strategy to reduce vascular inflammation, which may serve as a target for interventional studies in humans. 

Nathalie Beaufort / PostDoc

I grew up and studied in France, and obtained my doctoral thesis in Physiology and Physiopathology in 2005 at University Paris 6. After post-doctoral experiences in France and Germany, I joined the group of Martin Dichgans at the ISD in 2010 as a research associate. My work focusses on the biochemistry, cellular and molecular biology of cerebral small vessel disease with an emphasis on CARASIL, an inherited disorder caused by loss-of-function mutations targeting the HTRA1 protease. To explore the pathomechanisms underlying CARASIL and develop innovative repair strategies, I combine the analysis of recombinant proteins, patient-derived primary cells and mouse tissues.

Marios Georgakis / PhD student

Originally from Greece, I have studied medicine at the University of Athens (graduated in 2015) and completed Master studies in Neurosciences at the same University (2017). After an experience for 4 years as a research fellow in the field of epidemiology in Athens, I joined Martin Dichgans’ group at the ISD in 2017 as a PhD student of the Graduate School of Systemic Neurosciences. Here, I work on the genetic and clinical epidemiology of cerebrovascular disease. My main goal is to use genetic data to identify causal risk factors and novel therapeutic targets for stroke and cerebral small vessel disease. My research interests further lie in determining the causes and predictors of cognitive decline after stroke.

Pubmed | Google Scholar | ResearchGate | Twitter

Judit Gonzales Gallego / PhD student

I am born in Spain and obtained my BSc in biochemistry from the Autonomous University of Barcelona. After completing my bachelors degree, I worked for one year at the Center of Neurobiology of Hamburg University with Dr. Marina Mikhaylova in protein neuronal transport. Currently, I'm a student in the Graduate School of Systemic Neuroscience (GSN) and after performing a research internship in PaquetLab on CRISPR/Cas9 genome editing I decided to join the ISD in October 2018 for a PhD project in neurovascular disorders co-supervised by Martin Dichgans and Dominik Paquet.

Christof Haffner / senior scientist

I completed my studies in biology and my Ph.D. in clinical biochemistry at the University of Würzburg. After working as a Postdoc at Yale University, New Haven and at the University of Halle/Saale, I joined the Department of Metabolic Chemistry at the LMU in Munich. Since 2009 I am a senior researcher at the ISD, in 2011 I completed my habilitation in biochemistry at the LMU medical faculty. My work focuses on the molecular mechanisms of hereditary forms of cerebral small vessel disease, with a priority on Notch3 pathomechanisms in CADASIL.

Anna Kopczak / clinician scientist

Barbara Lindner / technical assistant

Rainer Malik / PostDoc

Originally from Austria, I studied molecular biology with a focus on computational biology and protein structure prediction at the University of Salzburg. As an early adopter in the bioinformatics field, I changed subject to further strengthen my computational knowledge and obtained my PhD in Computer Science at the Universiteit Utrecht in 2006. After a first PostDoc analyzing cell-cycle dependent proteomics data (Prof. Nigg, MPI Biochemistry, Martinsried), I joined the ISD at the very beginning in 2009 to analyze large-scale OMICS data. Here, over the last years, we have led or participated in all major genetic studies of stroke and stroke-related comorbidities. Through extensive international collaborations (ISGC, METASTROKE, MEGASTROKE) we strive to translate genetic, genomic and other OMICS findings to animal models and subsequently to the clinic.

Twitter: @rainermpg | Google Scholar

Matthias Prestel / PostDoc

I am a senior scientist with expertise in transcription, chromatin remodelling and epigenetics. I was recruited to the ISD in 2012. My research focuses on the functional characterization of genetically inherited risk loci identified in large case-control Genome-Wide Association Studies for large atherosclerotic stroke. I integrate biochemical, chromatin and cell biology methods to determine the molecular mechanism conferred by risk loci. As risk loci are often Single Nucleotide Polymorphisms in noncoding genome, they exert a regulatory function in chromatin organization and gene expression. To develop novel therapeutic approaches, it is crucial to understand the molecular link between risk loci and disease etiology. To this end, I work on identifying dysregulated target genes, characterizing their biological function and generating murine model systems to test their relevance in atherosclerosis.

Melanie Schneider / technical assistant

I finished my education as a medical technical assistant in 2005 and immediately started working with Professor Martin Dichgans. I take care of organizational issues to all groups, place orders and do many histology works for my group members (e. g. preparing and cutting tissue, do staining’s, microscopy and sometimes evaluations). I am currently involved in projects aimed at identifying the mechanism underlying proatherogenic role of HDAC9 and exploring the therapeutic potential of HDAC9 inhibition for atheroprotection.

Steffen Tiedt / clinician scientist

I joined the group of Martin Dichgans at the ISD in 2013 after finishing my medical studies at the LMU in Munich and at Harvard. Beforehand, I received an MD for studying the regeneration of neurons after stroke (with Magdalena Götz, Institute of Physiology, LMU). Since being part of the ISD, my main research goal is to identify circulating biomarkers for diagnostic questions posed in the context of stroke and translate them into daily clinical application. For this purpose we established the CIRCULAting biomarkers after Stroke (CIRCULAS) study in 2014, which recruits patients with suspected stroke in the emergency department and has a strong focus on biosampling of these patients in the acute and subacute phase. We apply omics technologies (eg, RNA sequencing) and single-molecule assays to study different molecular classes such as microRNAs, proteins, and metabolites to advance our understanding of the pathophysiology of stroke and for their value as biomarkers.

Pubmed | Google Scholar |  Research Gate

Katalin Völgyi

Guangyao Yan / PhD student

Born and bred in China, I finished veterinary medicine study in Yangzhou university in 2011 and received my master degree in animal genetics and stem cell research in Nanjing Agricultural university in 2014. After acquiring some molecular techniques and combined with innate love for basic research, I joined AG Dichgans in2015 as a doctoral candidate. My main PhD project aims to decipher the molecular role of HDAC9 during atherogenesis in cell types of interest. To achieve this goal, we exploited a new mouse model and utilized different molecular and cellular techniques. To further explore the function of HDAC9, transcriptomic sequencing was also performed and analyzed. Outside the lab, I often go hiking and biking in the alps and experience or learn something new. 

Gabriele Wagenstetter / MD student

Andreas Zellner / PhD student

Yishu Huang / PhD student

I studied Clinical Medicine and Psychology at Tongji Medical College, Huazhong University of Science and Technology. After obtaining my Master degree of Internal Medicine, I joined the Dichgans lab as a PhD candidate in 2018, and was later admitted into the International Research Training Group (IRTG) program of the Collaborative Research Center (CRC) 1123 Atherosclerosis. My scientific research aims at investigating the potential role of novel risk loci, which identified in large scaled GWAS studies, in atherosclerosis. Outside of the lab, I enjoy going to Staatsoper, collecting traditional Chinese chop seals and appreciating masterpieces of Kandinsky.

Karin Waegemann / research coordinator